Retracted] Activation of the LKB1‑SIK1 signaling pathway inhibits the TGF‑β‑mediated epithelial‑mesenchymal transition and apoptosis resistance of ovarian carcinoma cells
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion and migration assay data shown in Figs. 2C and 3F were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes, which had either already been published or were under consideration for publication at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 2837‑2844, 2018; DOI: 10.3892/mmr.2017.8229].
Errataetall: |
RetractionOf: Mol Med Rep. 2018 Feb;17(2):2837-2844. - PMID 29257268 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Molecular medicine reports - 29(2024), 4 vom: 21. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hong, Bo [VerfasserIn] |
---|
Links: |
---|
Themen: |
Apoptosis resi- stance |
---|
Anmerkungen: |
Date Revised 22.02.2024 published: Print-Electronic RetractionOf: Mol Med Rep. 2018 Feb;17(2):2837-2844. - PMID 29257268 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3892/mmr.2024.13180 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368236676 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368236676 | ||
003 | DE-627 | ||
005 | 20240222232549.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240209s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3892/mmr.2024.13180 |2 doi | |
028 | 5 | 2 | |a pubmed24n1302.xml |
035 | |a (DE-627)NLM368236676 | ||
035 | |a (NLM)38334182 | ||
035 | |a (PII)56 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hong, Bo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Retracted] Activation of the LKB1‑SIK1 signaling pathway inhibits the TGF‑β‑mediated epithelial‑mesenchymal transition and apoptosis resistance of ovarian carcinoma cells |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 22.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a RetractionOf: Mol Med Rep. 2018 Feb;17(2):2837-2844. - PMID 29257268 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion and migration assay data shown in Figs. 2C and 3F were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes, which had either already been published or were under consideration for publication at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 2837‑2844, 2018; DOI: 10.3892/mmr.2017.8229] | ||
650 | 4 | |a Retraction of Publication | |
650 | 4 | |a apoptosis resi- stance | |
650 | 4 | |a chemoresistant | |
650 | 4 | |a epithelial-mesenchymal transition | |
650 | 4 | |a liver kinase B1‑salt‑inducible kinase 1 | |
650 | 4 | |a ovarian carcinoma | |
650 | 4 | |a transforming growth factor-β | |
700 | 1 | |a Zhang, Jianmei |e verfasserin |4 aut | |
700 | 1 | |a Yang, Wenlan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular medicine reports |d 2008 |g 29(2024), 4 vom: 21. Feb. |w (DE-627)NLM192195727 |x 1791-3004 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2024 |g number:4 |g day:21 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.3892/mmr.2024.13180 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2024 |e 4 |b 21 |c 02 |